Ho C - Search Results

1

Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis.

Hamilton SN, Ho C, Laskin J, Zhai Y, Mak P, Wu J. Hamilton SN, et al. Among authors: ho c. Am J Clin Oncol. 2016 Dec;39(6):575-580. doi: 10.1097/COC.0000000000000091. Am J Clin Oncol. 2016. PMID: 24879476

2

Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America.

Ho C, Murray N, Laskin J, Melosky B, Anderson H, Bebb G. Ho C, et al. Lung Cancer. 2005 Aug;49(2):225-31. doi: 10.1016/j.lungcan.2005.02.011. Lung Cancer. 2005. PMID: 15925429

3

Side effects related to cancer treatment: CASE 1. Hepatitis following treatment with gefitinib.

Ho C, Davis J, Anderson F, Bebb G, Murray N. Ho C, et al. J Clin Oncol. 2005 Nov 20;23(33):8531-3. doi: 10.1200/JCO.2004.00.6650. J Clin Oncol. 2005. PMID: 16293881 No abstract available.

4

Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis.

Ho C, Ng K, O'Reilly S, Gill S. Ho C, et al. Clin Colorectal Cancer. 2005 Nov;5(4):279-82. doi: 10.3816/ccc.2005.n.040. Clin Colorectal Cancer. 2005. PMID: 16356306

5

Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.

Pugh TJ, Bebb G, Barclay L, Sutcliffe M, Fee J, Salski C, O'Connor R, Ho C, Murray N, Melosky B, English J, Vielkind J, Horsman D, Laskin JJ, Marra MA. Pugh TJ, et al. Among authors: ho c. BMC Cancer. 2007 Jul 13;7:128. doi: 10.1186/1471-2407-7-128. BMC Cancer. 2007. PMID: 17626639 Free PMC article.

6

EGFR-directed therapies to treat non-small-cell lung cancer.

Ho C, Laskin J. Ho C, et al. Expert Opin Investig Drugs. 2009 Aug;18(8):1133-45. doi: 10.1517/13543780903066772. Expert Opin Investig Drugs. 2009. PMID: 19572809 Review.

7

Primary tumor resection in patients presenting with metastatic colorectal cancer: analysis of a provincial population-based cohort.

Chan TW, Brown C, Ho CC, Gill S. Chan TW, et al. Among authors: ho cc. Am J Clin Oncol. 2010 Feb;33(1):52-5. doi: 10.1097/COC.0b013e31819e902d. Am J Clin Oncol. 2010. PMID: 19704367

8

Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study.

Goss GD, Arnold A, Shepherd FA, Dediu M, Ciuleanu TE, Fenton D, Zukin M, Walde D, Laberge F, Vincent MD, Ellis PM, Laurie SA, Ding K, Frymire E, Gauthier I, Leighl NB, Ho C, Noble J, Lee CW, Seymour L. Goss GD, et al. Among authors: ho c. J Clin Oncol. 2010 Jan 1;28(1):49-55. doi: 10.1200/JCO.2009.22.9427. Epub 2009 Nov 16. J Clin Oncol. 2010. PMID: 19917841 Clinical Trial.

9

Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC).

Jagdis A, Laskin J, Hao D, Hay J, Wu J, Ho C. Jagdis A, et al. Among authors: ho c. Am J Clin Oncol. 2014 Feb;37(1):63-9. doi: 10.1097/COC.0b013e31826b9b1a. Am J Clin Oncol. 2014. PMID: 23111356

10

The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: OaSIS - Outcomes and Surveillance Integration System.

Wu J, Ho C, Laskin J, Gavin D, Mak P, Duncan K, French J, McGahan C, Reid S, Chia S, Cheung H. Wu J, et al. Among authors: ho c. Stud Health Technol Inform. 2013;183:98-103. Stud Health Technol Inform. 2013. PMID: 23388263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,965 results

Search Page

Filters